Cargando…
The renin angiotensin aldosterone system and COVID-19
The ongoing pandemic has stimulated study of the Renin Angiotensin Aldosterone System (RAAS), and how it can be manipulated to treat COVID-19. Studies are examining whether drugs that act on the RAAS system might be useful to treat COVID-19. COVID-19 and the RAAS are closely linked both in infection...
Autores principales: | Alsufyani, Hadeel A., Docherty, James R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332203/ https://www.ncbi.nlm.nih.gov/pubmed/32788834 http://dx.doi.org/10.1016/j.jsps.2020.06.019 |
Ejemplares similares
-
Renin–Angiotensin System Implications to COVID-19 Comorbidities
por: Alsufyani, Hadeel A., et al.
Publicado: (2020) -
Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19
por: Jarcho, John A., et al.
Publicado: (2020) -
Renin-angiotensin-aldosterone system and COVID-19 infection
por: Alexandre, Joachim, et al.
Publicado: (2020) -
Covid-19, hypokalaemia and the renin-angiotensin-aldosterone system
por: Mandal, Amit.K.J., et al.
Publicado: (2021) -
Renin-Angiotensin-Aldosterone Inhibitors and COVID-19
por: Benenson, Irina, et al.
Publicado: (2020)